CD8A and neoplasm: Although some studies showed that tumor‐associated CD45‐positive cells,37, 38 tumor‐infiltrating lymphocytes,37 and CD8+ T cells39 in SCLC specimens were a good clinical marker to identify patients with favorable prognosis, but there was no significant association between CD45‐positive cell counts and advanced disease stage.40